70. Spinal stenosis Clinical trials / Disease details


Clinical trials : 95 Drugs : 169 - (DrugBank : 61) / Drug target genes : 68 - Drug target pathways : 90

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04483297
(ClinicalTrials.gov)
November 18, 202014/7/2020First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion SurgeryDegenerative Spondylolisthesis;Spinal StenosisDrug: AK1320 MS;Other: ControlAsahi Kasei Pharma CorporationEmergent Clinical Consulting, LLCActive, not recruiting22 Years80 YearsAll40Phase 1Canada